Compound: Tivozanib

Drug Target: VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.